Reported Reactions

Devices › Device types

FDA product code CDD · class 2 · Clinical Chemistry

Radioassay, vitamin b12: medical device reports filed with FDA

358 reports carry this product code, 1995–2026; 3 brands with a page.

358
reports with this product code
0% of all MAUDE reports
28
reports, 12 months to August 2026
52 in the 12 months before
86.6%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code CDD is FDA's classification for "Radioassay, vitamin b12" (clinical Chemistry panel), a class 2 device. 358 medical device reports carry this product code, 0% of the MAUDE database, from October 1995 to August 2026.

28 reports arrived in the 12 months to August 2026, down 46% from 52 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (86.6%), injury (12.6%) and other (0.6%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Dimension Vista Clinical Chemistry System900.2%99.4%
Access 2 Immunoassay Analyzer4130%73.5%
Cobas 8000 E602 Module100%99.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Beckman Coulter6518.2%
Siemens Healthcare Diagnostics328.9%
A I D D Longford308.4%
Abbott Ireland Diagnostics Division92.5%
Siemens Healthcare Diagnostics - Glasgow92.5%
Abbott Germany61.7%
Abbott Ireland41.1%

Reports by month, five years

048Sep 2021: 3Oct 2021: 3Nov 2021: 0Dec 2021: 32022Jan 2022: 1Feb 2022: 1Mar 2022: 2Apr 2022: 1May 2022: 2Jun 2022: 4Jul 2022: 1Aug 2022: 4Sep 2022: 3Oct 2022: 1Nov 2022: 1Dec 2022: 32023Jan 2023: 1Feb 2023: 2Mar 2023: 6Apr 2023: 0May 2023: 1Jun 2023: 2Jul 2023: 6Aug 2023: 4Sep 2023: 1Oct 2023: 1Nov 2023: 2Dec 2023: 12024Jan 2024: 4Feb 2024: 2Mar 2024: 1Apr 2024: 2May 2024: 3Jun 2024: 3Jul 2024: 4Aug 2024: 0Sep 2024: 4Oct 2024: 1Nov 2024: 5Dec 2024: 42025Jan 2025: 6Feb 2025: 1Mar 2025: 2Apr 2025: 7May 2025: 8Jun 2025: 3Jul 2025: 4Aug 2025: 7Sep 2025: 2Oct 2025: 3Nov 2025: 1Dec 2025: 12026Jan 2026: 3Feb 2026: 1Mar 2026: 3Apr 2026: 4May 2026: 1Jun 2026: 2Jul 2026: 5Aug 2026: 2

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%0
Injury12.6%45
Malfunction86.6%310
Other0.6%2
Not given0.3%1

Who filed

Manufacturer report99.7%357
Voluntary report0.3%1
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
High test results14741.1%
Low test results8022.3%
Incorrect or inadequate test results5114.2%
Non reproducible results339.2%
Incorrect, inadequate or imprecise result or readings328.9%
Device handling problem72%
Imprecise or erratic results51.4%
Low readingsreadings were too low41.1%
Patient device interaction problem41.1%
False positive result30.8%
Imprecision30.8%
Nonstandard device30.8%
Calibration problem20.6%
Device operates differently than expectedthe device behaved unexpectedly20.6%
Improper or incorrect procedure or method20.6%
Incorrect measurementthe device measured wrongly20.6%
Output problem20.6%
Patient data problem20.6%
Breakthe device broke10.3%
Chemical problem10.3%

Questions about radioassay, vitamin b12 reports

What is product code CDD?

FDA's classification code for "Radioassay, vitamin b12", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.

How many reports carry this code?

358 reports through August 2026, 28 of them in the latest 12 months.

Which brands appear most often?

Dimension Vista Clinical Chemistry System (9), Access 2 Immunoassay Analyzer (4) and Cobas 8000 E602 Module (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.